Ivermectin and UBI.

Ultraviolet Blood Irradiation (UBI) is an intravenous (IV) procedure that draws a small amount of blood, exposes it to UV light (specifically UVa, UVb, and UVc) to deactivate pathogens, and reinfuses it to stimulate the immune system and reduce inflammation. It is used for chronic infections, autoimmune diseases, and to improve circulation, often as an integrative therapy.

Key Details About UBI Therapy: Procedure: Typically, a small volume of blood (2-10 mL per 10 lbs of body weight) is removed, irradiated with UV light, and returned to the patient. It is often performed in conjunction with ozone therapy.

Mechanism: UV light damages the DNA/RNA of bacteria and viruses, inactivating them, while modulating the immune system, such as increasing white blood cell production.

Conditions Treated: UBI is used for acute/chronic bacterial, viral, and fungal infections, cancer, autoimmune diseases (e.g., lupus, RA), allergies, and cardiovascular issues.

Treatment Frequency: Sessions generally last under an hour and are often done 1-2 times per week, with chronic conditions potentially requiring maintenance.

History & Status: Developed in the 1940s/50s for infections like septicemia and pneumonia, UBI fell out of favor with the rise of antibiotics, leading to it being called "the cure that time forgot". It is still considered a controversial, alternative, or functional medicine approach in many Western countries.

Potential Benefits and Safety: Immune System Boost: It is believed to increase oxygen absorption and boost the immune response.

Safety: While some studies suggest it is effective without significant adverse effects, it is generally considered an alternative treatment.